Description: Christopher R. Cogle, M.D., an associate professor of hematology and oncology in the UF College of Medicine, talks with Kim White, who is being treated for a blood disorder known as MDS. (Photo by Maria Farias/University of Florida)
Description: Hendrik Luesch, Qi-Yin Chen and Yanxia Liu, researchers with the UF College of Pharmacy, found how a byproduct of cyanobacteria can be modified for potential use as a cancer therapy. (Photo by Maria Farias/University of Florida)
Description: Johannes Vieweg, M.D., executive director of the UF Prostate Disease Center and Thomas Crawford, M.B.A., the chief operating officer of the UF Prostate Disease Center
Description: Shands Medical Plaza, Davis Cancer Center, Emerging Pathogens Institute and Cancer Genetics Research Center. Photo by Jesse Jones/University of Florida
Description: Christopher Cogle, M.D., associate professor of medicine, division hematology and oncology, UF College of Medicine and Peter Sayeski, Ph.D., associate professor, department of physiology and functional genomics, UF College of Medicine. (Photo by Maria Farias/University of Florida)
Description: Dr. Philipp Dahm's study fndings have shown that routine prostate cancer screening does not benefit patients. Dr. Dahm is a urologist, an a pioneer in evidence-based urology. (Photo By Maria Belen Farias/University of Florida)
Description: Thomas George Jr., M.D., a member of the UF Shands Cancer Center and director of UF’s Gastrointestinal Oncology Program in the College of Medicine.
Description: Wesley E. Bolch, Ph.D., a professor in the UF departments of nuclear and radiological engineering and biomedical engineering, and a member of the UF Shands Cancer Center.